Significantly less desire for salty snacks over the next nine hours compared to placebo with just one dose of greens
One area where Semaglutide maintains advantage involves cardiovascular outcome data
At minimum: hsCRP, IL-6 (if your lab offers it), fasting insulin, HbA1c, complete metabolic panel, thyroid function, vitamin D level, and a complete blood count
Patients should be reviewed at 36 month intervals to assess treatment response, tolerability, and ongoing appropriateness of therapy
Oral Wegovy / Oral Semaglutide FAQs Considering a needle-free GLP-1 option
Curr Alzheimer Res 11(2):165174 Kato D et al (2022) Comparative studies for amyloid beta degradation:neprilysin vs insulysin,monomeric vs aggregate, and whole A40 vs its peptide fragments